Prakt. Lékáren. 2018; 14(2e) [Med. praxi. 2018;15(1):38-42]

L-tryptofan – a nutraceutical with impact on mental health

Dana Kamarádová1, Vilím Šimánek2
1 Klinika psychiatrie, Fakultní nemocnice Olomouc
2 Ústav lékařské chemie a biochemie LF UP, Olomouc

L-tryptophan is an essential amino acid of the human diet. Apart from its incorporation into body proteins, L-tryptophan is the precursor ofserotonin and other neurotransmitters in the brain and gastro intestinal tract. This brief overview covers the role of L-tryptophan in brain serotoninsynthesis as an important factor in mood, cognition and social behaviour.

Keywords: L-tryptophan, nutrition, metabolites, 5-hydroxytryptophan, serotonin, mood disorder, behaviour

Received: March 15, 2017; Accepted: March 20, 2017; Published: June 20, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kamarádová D, Šimánek V. L-tryptofan – a nutraceutical with impact on mental health. Pharmacy for Practice. 2018;14(E-verze 2/18):.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Richard DM, Dawes MA, Mathias CW, Acheson A, Hill-Kapturczak N, Dougherty DM. L-Tryptophan: Basic metabolic functions, behavioral research and therapeutic indications. Inter J Tryp Res. 2009; 2: 42-60. Go to original source... Go to PubMed...
    2. Le Floch N, Otten WE. Tryptophan metabolism from nutrition to potential therapeutic application. Amino Acids. 2011; 41(5): 1195-1105. Go to original source... Go to PubMed...
    3. Scientific Opinion on the substantiation of health claims related to L-tryptophan and maintenance of normal sleep (ID 596, 1671), enhancement of mood (ID 596), contribution to normal cognitive function (ID 596), and contribution to the maintenance or achievement of a normal body weight (ID 604) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011; 9(4): 2073 [16 pp.]. doi:10.2903/j.efsa.2011.2073. Go to original source...
    4. Scientific Opinion on the substantiation of health claims related to 5-hydroxytryptophan and enhancement of mood (ID 1575) and attention (ID 1828) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal 2009; 7(9): 1273. [11 pp.]. doi:10.2903/j.efsa.2009.1273.
    5. Kreibig SD. Autonomic nervous system activity in emotion: a review. Biol Psychol. 2010; 84(3): 394-421. Go to original source... Go to PubMed...
    6. Woodward SH, Arsenault NJ, Voelker K, et al. Autonomic activation during sleep in posttraumatic stress disorder and panic: a mattress actigraphic study. Biol Psychiatry. 2009; 66(1): 41-46. Go to original source... Go to PubMed...
    7. Porges SW. The polyvagal theory: phylogenetic substrates of a social nervous system. Int J Psychophysiol. 2001; 42(2): 123-146. Go to original source... Go to PubMed...
    8. Selye H. Confusion and controversy in the stress field. J Human Stress. 1975; 1(2): 37-44. Go to original source... Go to PubMed...
    9. Raboch J, Uhlíková P, Hellerová P, Anders M, Šusta M. Psychiatrie: Doporučené postupy v psychiatrické péči. Psychiatrická společnost ČLS JEP 2014.
    10. Kopeček M. Dopis redakci. Psychiatrie 2016; 20(2): 115-116.
    11. Kamarádová D, Látalová K, Praško J, et al. Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adherence. 2016; 10: 1289-1298. Go to original source... Go to PubMed...
    12. López-Mu?oz F, Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009; 15(14): 1563-1586.
    13. Ashcroft GW, Crawford TBB, Eccleston D, Sharman DF, Macdougall E, Stanton JB, Binns JK. 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet. 1966; 288: 1049-1052. Go to original source... Go to PubMed...
    14. Higginbotham E, Taub PR. Cardiovascular Benefits of Dark Chocolate? Curr Treat Options Cardiovasc Med. 2015; 17(12): 54. Go to original source... Go to PubMed...
    15. Shakersain B, Santoni G, Larsson SC, Faxén-Irving G, Fastbom J, Fratiglioni L, Xu W. Prudent diet may attenuate the adverse effects of Western diet on cognitive decline. Alzheimers Dement. 2016; 12(2): 100-109. Go to original source... Go to PubMed...
    16. Mocking RJ, Harmsen I, Assies J, Koeter MW, Ruhé HG, Schene AH. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry. 2016; 6: e756. Go to original source... Go to PubMed...
    17. Steenbergen L, Jongkees BJ, Sellaro R, Colzato LS. Tryptophan supplementation modulates social behavior: A review. Neurosci Biobehav Rev. 2016; 64: 346-358. Go to original source... Go to PubMed...
    18. Hogenelst K, Schoevers RA, aan het Rot M. The effects of tryptophan on everyday interpersonal encounters and social cognitions in individuals with a family history of depression. Inter J Neuropsychopharm. 2015: 1-8. Go to original source... Go to PubMed...
    19. Moskowitz DS, Zuroff DC, Aan het Rot M, Young SN. Tryptophan and interpersonal spin. J Res Personalit. 2011; 45(6): 692-696. Go to original source...
    20. Young SN. The effect of raising and lowering tryptophan levels on human mood and social behaviour. Phil Trans R Soc B 2013; 368(1615): 20110375. Go to original source... Go to PubMed...
    21. Shaw KA, Turner J, Del Mar C. Tryptophan and 5-Hydroxytryptophan for depression. Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD003198. doi: 10.1002/14651858.CD003198. Go to original source...
    22. Badawy AAB. Tryptophan metabolism in alcoholism. Nutrition research reviews. 2002; 15(1): 123-152. Go to original source... Go to PubMed...
    23. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003; 53(8): 649-659. Go to original source... Go to PubMed...
    24. Jacobsen JPR, Krystal AD, Krishnan KRR, Caron MG. Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale. Trends Pharmacol Sci. 2016; 37(11): 933-944. Go to original source... Go to PubMed...
    25. Thomas SR. l-Tryptophan as an antidepressive agent in the management of treatment-resistant unipolar depression in borderline personality disorder: Three case reports. Advances in Integrative Medicine. 2015; 2(1): 68-71. Go to original source...
    26. Hale AS, Procter AW, Bridges PK. Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies. Br J Psychiatry. 1987; 151: 213-217. Go to original source... Go to PubMed...
    27. Levitan RD, Shen JH, Jindal R, Driver HS, Kennedy SH, Shapiro CM. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects. J Psychiatry Neurosci. 2000; 25(4): 337-346.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.